
Private equity firm investing in scaling technology businesses across North America, Latin America and emerging markets

Drug discovery and development services company working with pharma and biotech partners

Describing itself as pioneering the future of drug discovery and preclinical development, Evotec is a life science company. It works with partners to shorten the journey from concept to treatment, combining technology, science and disease knowledge across modalities from small molecules to biotherapeutics. The company is based in Hamburg, Germany, and its group includes the Cyprotex, Aptuit and Just Evotec Biologics brands.
The discovery work covers target identification and validation, hit identification, sample management and chemistry. Alongside these sit antibody discovery and drug discovery services, plus research informatics and in silico drug discovery. Its proteomics and metabolomics work, bio-reagents and in vitro iPSC research services give partners further tools for studying biology. The company describes PanHunter, its platform for multi-omics data analysis, as a next-generation tool.
Preclinical work includes DMPK and ADME-Tox studies, in vitro and in vivo biology, in vivo pharmacology and biomarker work. The company also offers safety assessment, which covers pathology, bioanalysis, ADME, abuse liability assessment and SEND work, and it brings these together as integrated preclinical development. Its research services sit within a fully integrated R&D value chain that the company says delivers speed, efficiency and quality.
Biotherapeutics is a major area, run in part through the Just Evotec Biologics unit. The company says that unit has changed how biologics are designed, developed and made, widening access to high-quality treatments. Antibody discovery and an integrated antibody research and development service sit alongside it, giving partners a route from target to biologic candidate.
Development and manufacturing cover analytical development and quality control, pre-clinical formulation, drug product development and manufacturing, and an integrated inhalation capability. Under its chemistry, manufacturing and controls work the company lists material sciences, active pharmaceutical ingredient capabilities and integrated CMC support. It also offers global regulatory affairs support.
Its disease focus includes anti-infective work, immunology and inflammation, metabolic conditions, neuroscience, oncology, rare conditions and respiratory medicine. The company describes its partnering models as flexible, and says its approach lets treatments reach patients sooner.
Evotec is a life sciences company that provides drug discovery and development services. Its work runs from finding and validating targets through to preclinical and manufacturing stages.
Partners in therapeutic areas including oncology, neuroscience, immunology and inflammation, metabolic diseases, respiratory conditions, anti-infectives and rare diseases. It has announced a collaboration and licence agreement with Janssen Biotech.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
No questions yet. Be the first to ask about Evotec.
Similar listings buyers compare against this one.

Private equity firm investing in scaling technology businesses across North America, Latin America and emerging markets

Venture investor backing technology entrepreneurs across sectors such as HR, fintech, insurance and health

Oslo investment company with holdings in industrial businesses, property and funds since 1932

Investment manager running funds for early and growth-stage startups across many sectors

Founder-first venture capital firm investing across sectors in startups worldwide, with a global founder community

Semiconductor and sensing company selling components and design tools to engineers in industrial, automotive and healthcare markets

Corporate venture arm of a renewable energy group backing early-stage energy technology companies

Binational foundation funding joint research and development projects between American and Israeli companies
Everything here links back to the same verified catalogue. Pick your next stop.